Randomised, Double-blind, Placebo-controlled Study of Topical Clobetasone Butyrate 0.05% Cream in Subjects With Eczema for Two Weeks to Evaluate the Efficacy and Safety

NCT01567995 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Eczema

Interventions

DRUG: Clobetasone Butyrate 0.05% Cream
DRUG: Vehicle (base cream)

Sponsor

GlaxoSmithKline